-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Initiates Coverage On DarioHealth with Buy Rating, Announces Price Target of $6

Benzinga·10/27/2026 09:55:13
Listen to the news
BTIG analyst David Larsen initiates coverage on DarioHealth (NASDAQ:DRIO) with a Buy rating and announces Price Target of $6.